A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
The in vivo capability of Saccharomyces cerevisiae (SC), and of an esterified glucomannan (EGM) to reduce the oral bioavailability of ochratoxin A (OTA) added to a basal diet for laying hens was checked over a 12 week period. The residues of OTA in kidney, muscle and blood were studied. Eighty-four Isa Brown laying hens were divided into 6 experimental groups, fed 6 different diets: 0-0: basal diet; EGM-0: diet supplemented with 0.2% EGM; SC-0: diet supplemented with 0.2% SC; 0-OTA: dietdoi:10.4081/ijas.2007.1s.737 fatcat:zilbf2zr5rfdbg3iu5fajd4jw4